KunWha Pharmaceutical Co., Ltd. (KOSE:A002250) has been chosen as the preferred bidder to buy Hanwha Corp.'s (KOSE:A000880) Dream Pharma Corp., according to sources on July 3, 2014. Kunwha Pharmaceuticals will exercise its right to enter into exclusive negotiations for two weeks.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25,950 KRW | -0.95% | -4.42% | +0.78% |
05-22 | Hanwha Group Names New Head of North American Investments | MT |
05-16 | White House moves to protect US solar manufacturers from Chinese competition | RE |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.78% | 1.41B | |
+13.67% | 80.01B | |
+10.19% | 51.82B | |
+6.25% | 49.81B | |
+22.88% | 47.26B | |
+15.22% | 42.91B | |
+22.43% | 39.1B | |
+1.09% | 29.53B | |
-2.30% | 29.24B | |
-12.31% | 27.29B |
- Stock Market
- Equities
- A000880 Stock
- News Hanwha Corporation
- Kunwha Reportedly Named As Preferred Bidder For Dream Pharma